| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Qing-Chun Huang | |
| Run-Yue Huang | |||
| Xiao-Hong He | |||
| Mao-Jie Wang | |||
| Xiu-Min Chen | |||
| Wan-Lin Yu | |||
| Yong-Liang Chu | |||
| P2860 | cites work | The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer | Q24298074 |
| Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies | Q28237085 | ||
| High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage | Q28513347 | ||
| Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans | Q30486725 | ||
| Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands. | Q31143760 | ||
| Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture | Q33554055 | ||
| Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus | Q33555976 | ||
| Health-promoting properties of common herbs | Q33729661 | ||
| Anti-inflammatory effects of licorice and roasted licorice extracts on TPA-induced acute inflammation and collagen-induced arthritis in mice | Q33737485 | ||
| Licorice and cancer | Q34393257 | ||
| Nimesulide improves the symptomatic and disease modifying effects of leflunomide in collagen induced arthritis | Q34465735 | ||
| Inhibition of cyclooxygenase‐2 prevents adverse effects induced by phosphodiesterase type 4 inhibitors in rats | Q34540209 | ||
| Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors | Q44537365 | ||
| Itraconazole: its possible role in inhibiting angiogenesis in rheumatoid arthritis | Q46895012 | ||
| Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice | Q46965726 | ||
| Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats | Q48023403 | ||
| Separation and characterization of phenolic compounds and triterpenoid saponins in licorice (Glycyrrhiza uralensis) using mobile phase-dependent reversed-phase×reversed-phase comprehensive two-dimensional liquid chromatography coupled with mass spec | Q53493352 | ||
| Prevention of stroke in rheumatoid arthritis. | Q53502883 | ||
| The influence of synovial fluid exudates from patients with rheumatoid arthritis on the proliferation of peripheral blood lymphocytes and the prostanoid release from monocytes | Q71104005 | ||
| PGE2, PGF2 alpha, and TXB2 biosynthesis by human rheumatoid synovia | Q71201872 | ||
| Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis | Q71763838 | ||
| Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2) | Q73236748 | ||
| Glycyrrhizin Treatment Is Associated with Attenuation of Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Expression | Q82444724 | ||
| Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational study | Q84110564 | ||
| [Effect of glycyrrhetinic acid on the expression of inflammatory factors in fibroblast-like synovial cells from collagen induced arthritis rats] | Q84974911 | ||
| 4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor | Q84983692 | ||
| 18-β Glycyrrhetinic acid alleviates 2-acetylaminofluorene-induced hepatotoxicity in Wistar rats: Role in hyperproliferation, inflammation and oxidative stress | Q85888319 | ||
| Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs | Q34585457 | ||
| Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology | Q34765395 | ||
| 18β-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer | Q35138733 | ||
| Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation | Q35176423 | ||
| Licochalcone A, a polyphenol present in licorice, suppresses UV-induced COX-2 expression by targeting PI3K, MEK1, and B-Raf | Q35380336 | ||
| Balancing gastroprotection and cardioprotection with selective cyclo-oxygenase-2 inhibitors: clinical implications | Q35570035 | ||
| Management of rheumatoid arthritis in People's Republic of China - focus on tocilizumab and patient considerations | Q35618458 | ||
| Activating enhancer-binding protein-2α induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growth | Q35741600 | ||
| Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs | Q35742534 | ||
| Cyclooxygenase-2 inhibitors: a painful lesson | Q36512725 | ||
| New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: focus on use in the elderly | Q36850339 | ||
| Can licorice lick colon cancer? | Q37143412 | ||
| Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid | Q37636900 | ||
| Cigarette smoking, cyclooxygenase-2 pathway and cancer | Q37819321 | ||
| Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis | Q38018879 | ||
| Malignancy risks with biologic therapies | Q38058592 | ||
| The cyclooxygenase-2/thromboxane A2 pathway: a bridge from rheumatoid arthritis to lung cancer? | Q38244319 | ||
| The licorice flavonoid isoliquiritigenin suppresses phorbol ester-induced cyclooxygenase-2 expression in the non-tumorigenic MCF-10A breast cell line. | Q38347680 | ||
| Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges | Q38357554 | ||
| Is non-biological treatment of rheumatoid arthritis as good as biologics? | Q38385089 | ||
| Analysis of patents on anti-rheumatoid arthritis therapies issued in China | Q38525320 | ||
| Dehydroglyasperin C suppresses TPA-induced cell transformation through direct inhibition of MKK4 and PI3K. | Q38897786 | ||
| Determination of role of thromboxane A2 in rheumatoid arthritis | Q38914795 | ||
| Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase | Q39022082 | ||
| Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells | Q39037809 | ||
| Thromboxane A2 receptor α promotes tumor growth through an autoregulatory feedback pathway | Q39081913 | ||
| Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions. | Q39530011 | ||
| Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib | Q39683930 | ||
| Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography/tandem mass spectrometry | Q40706324 | ||
| IL-1β/HMGB1 complexes promote The PGE2 biosynthesis pathway in synovial fibroblasts | Q41394835 | ||
| Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management | Q41868896 | ||
| Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis | Q41921544 | ||
| Therapeutic effect of combined triptolide and glycyrrhizin treatment on rats with collagen induced arthritis | Q42167109 | ||
| Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells | Q42710528 | ||
| Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities | Q42828870 | ||
| Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. | Q43028580 | ||
| Celecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis. | Q43971550 | ||
| Coxibs: highly selective cyclooxygenase-2 inhibitors. Part II. Side effects | Q44516684 | ||
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eukaryote | Q19088 |
| hydrocarbon | Q43648 | ||
| rheumatoid arthritis | Q187255 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1193-202 | |
| P577 | publication date | 2016-01-12 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis? | |
| P478 | volume | 7 |
| Q57113795 | 18β-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1/FXR signaling pathway |
| Q54987320 | 18β-glycyrrhetinic acid inhibits migration and invasion of human gastric cancer cells via the ROS/PKC-α/ERK pathway. |
| Q92619215 | Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model |
| Q33786900 | Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro. |
| Q97524421 | The "Treatise on the spleen and stomach" (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature - A hypothesis based on the analysis of clinical presentation and herbal medicine |
| Q33631051 | Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation |
Search more.